CoChat

Efferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Type II alveolar epithelial cell (AEC) apoptosis is a prominent feature of fibrotic lung diseases and animal models of pulmonary fibrosis. While there is growing recognition of the importance of AEC injury and apoptosis as a causal factor in fibrosis, the underlying mechanisms that link these processes remain unknown. We have previously shown that targeting the type II alveolar epithelium for injury by repetitively administering diphtheria toxin to transgenic mice expressing the diphtheria toxin receptor off of the surfactant protein C promoter (SPC-DTR) develop lung fibrosis, confirming that AEC injury is sufficient to cause fibrosis. In the present study, we find that SPC-DTR mice develop increased activation of caspase 3/7 after initiation of diphtheria toxin treatment consistent with apoptosis within AECs. We also find evidence of efferocytosis, the uptake of apoptotic cells, by alveolar macrophages in this model. To determine the importance of efferocytosis in lung fibrosis, we treated cultured alveolar macrophages with apoptotic type II AECs and found that the uptake induced pro-fibrotic gene expression. We also found that the repetitive intrapulmonary administration of apoptotic type II AEC or MLE-12 cells induces lung fibrosis. Finally, mice lacking a key efferocytosis receptor, CD36, developed attenuated fibrosis in response to apoptotic MLE-12 cells. Collectively, these studies support a novel mechanism linking AEC apoptosis with macrophage pro-fibrotic activation via efferocytosis and reveal previously unrecognized therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-1074-z

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Increased lung apoptosis following targeted type II alveolar epithelial cell injury. a Transgenic SPC-DTR mice treated with daily doses of diphtheria toxin (DT, 10 µg/kg i.p.) for 14 days have increased levels of active caspase 3/7 compared to WT mice. N = 4, p < 0.01. b Two days after daily doses of diphtheria toxin (DT, 10 µg/kg i.p.) bronchoalveolar lavage cells were stained H&E (100x). A subset of alveolar macrophages contain apoptotic bodies (arrowhead)
Fig. 1 Increased lung apoptosis following targeted type II alveolar epithelial cell injury. a Transgenic SPC-DTR mice treated with daily doses of diphtheria toxin (DT, 10 µg/kg i.p.) for 14 days have increased levels of active caspase 3/7 compared to WT mice. N = 4, p < 0.01. b Two days after daily doses of diphtheria toxin (DT, 10 µg/kg i.p.) bronchoalveolar lavage cells were stained H&E (100x). A subset of alveolar macrophages contain apoptotic bodies (arrowhead)CC BY · PubMed Central
Fig. 2 Alveolar macrophage efferocytosis of apoptotic type II alveolar epithelial cells induces an alternatively activated (M2) polarization a, b Overlay images (20×) of phase and fluorescent microscopy images of cultured alveolar macrophages treated under control conditions (a) or treated for 2 h with UV-exposed GFP-labeled primary alveolar epithelial cells (b). c RT-qPCR expression analysis of cultured primary alveolar macrophages treated UV-treated primary AECs or without (control) for 24 h. d TGFβ ELISA of conditioned media from alveolar macrophages treated UV-treated primary AECs for 24 h. N = 4, *p < 0.05 compared to unstimulated macrophages
Fig. 2 Alveolar macrophage efferocytosis of apoptotic type II alveolar epithelial cells induces an alternatively activated (M2) polarization a, b Overlay images (20×) of phase and fluorescent microscopy images of cultured alveolar macrophages treated under control conditions (a) or treated for 2 h with UV-exposed GFP-labeled primary alveolar epithelial cells (b). c RT-qPCR expression analysis of cultured primary alveolar macrophages treated UV-treated primary AECs or without (control) for 24 h. d TGFβ ELISA of conditioned media from alveolar macrophages treated UV-treated primary AECs for 24 h. N = 4, *p < 0.05 compared to unstimulated macrophagesCC BY · PubMed Central
Fig. 3 Alveolar macrophages efferocytose apoptotic type II alveolar epithelial cells in vivo. a, b Flow cytometetry of BAL cells labeled with PE-conjugated anti-mouse CD45 antibody from WT mice 2 h after delivery of PBS only (control) (a) or GFP-labeled apoptotic type II alveolar epithelial cells (AEC) (b). c, d Fluorescent microscopy (100x) of BAL cytospins labeled with PE-conjugated anti-mouse CD45 antibody from WT mice 2 h after delivery of PBS (c) or GFP-labeled apoptotic AECs (d). A dual-positive cell stained for CD45 and GFP is demonstrated (arrowhead)
Fig. 3 Alveolar macrophages efferocytose apoptotic type II alveolar epithelial cells in vivo. a, b Flow cytometetry of BAL cells labeled with PE-conjugated anti-mouse CD45 antibody from WT mice 2 h after delivery of PBS only (control) (a) or GFP-labeled apoptotic type II alveolar epithelial cells (AEC) (b). c, d Fluorescent microscopy (100x) of BAL cytospins labeled with PE-conjugated anti-mouse CD45 antibody from WT mice 2 h after delivery of PBS (c) or GFP-labeled apoptotic AECs (d). A dual-positive cell stained for CD45 and GFP is demonstrated (arrowhead)CC BY · PubMed Central
Fig. 4 Efferocytosis of UV treated primary alveolar epithelial cells induces fibrosis. a, b Trichome stained lung sections (20 × ) from mice 21 days after initial delivery of live (a) or UV-treated primary alveolar epithelial cells (AECs) (b). c Hydroxyproline assay of lungs from mice treated daily doses of PBS, live AECs or UV-treated AECs for 7 days and analyzed 21 days after the initial dose, n = 6/group
Fig. 4 Efferocytosis of UV treated primary alveolar epithelial cells induces fibrosis. a, b Trichome stained lung sections (20 × ) from mice 21 days after initial delivery of live (a) or UV-treated primary alveolar epithelial cells (AECs) (b). c Hydroxyproline assay of lungs from mice treated daily doses of PBS, live AECs or UV-treated AECs for 7 days and analyzed 21 days after the initial dose, n = 6/groupCC BY · PubMed Central
Fig. 5 Efferocytosis of UV-treated MLE-12 cells induces fibrosis. a Hydroxyproline assay of lungs from mice treated with three times weekly doses of PBS (control) or UV-treated MLE-12 cells for 21 days, N = 6/group. b TGFβ ELISA of BAL fluid from mice treated with three times weekly doses of PBS or UV-treated MLE-12 cells for 21 days, N = 6/group. c, d Distribution of fibrosis is shown by picrosiris red stained lung sections (40x) from mice treated with three times weekly doses of PBS (c) or UV-treated MLE-12 cells (d) for 21 days
Fig. 5 Efferocytosis of UV-treated MLE-12 cells induces fibrosis. a Hydroxyproline assay of lungs from mice treated with three times weekly doses of PBS (control) or UV-treated MLE-12 cells for 21 days, N = 6/group. b TGFβ ELISA of BAL fluid from mice treated with three times weekly doses of PBS or UV-treated MLE-12 cells for 21 days, N = 6/group. c, d Distribution of fibrosis is shown by picrosiris red stained lung sections (40x) from mice treated with three times weekly doses of PBS (c) or UV-treated MLE-12 cells (d) for 21 daysCC BY · PubMed Central
Fig. 6 CD36-null mice exhibit less apoptotic type II AEC efferocytosis. a BAL cells from WT mice (control) or CD36-null mice 2 h after delivery of PBS or GFP-labeled apoptotic MLE-12 cells were labeded with PE-conjugated anti-mouse CD45 antibody and the percent efferocytosis is quantified by flow cytometry. b-d Representative flow cytometry plots of PBS treated WT control mice (b), UV GFP MLE-12 treated WT mice (c) and UV GFP MLE-12 treated CD36-null mice (d). N = 6 per group
Fig. 6 CD36-null mice exhibit less apoptotic type II AEC efferocytosis. a BAL cells from WT mice (control) or CD36-null mice 2 h after delivery of PBS or GFP-labeled apoptotic MLE-12 cells were labeded with PE-conjugated anti-mouse CD45 antibody and the percent efferocytosis is quantified by flow cytometry. b-d Representative flow cytometry plots of PBS treated WT control mice (b), UV GFP MLE-12 treated WT mice (c) and UV GFP MLE-12 treated CD36-null mice (d). N = 6 per groupCC BY · PubMed Central
Fig. 7 CD36-null mice are protected from efferocytosis-induced fibrosis. Twenty-one days after three times weekly doses of UV-treated MLE-12 cells, CD36-null mice has less fibrosis assessed by hyroxyproline assay (a) BAL fluid TGFβ measured by ELISA (b) and distribution of fibrosis assessed by histology (20×) of picrosiris red stained lungs slices of PBS treated control mice (c), UV MLE-12 injured WT mice (d), and UV MLE-12 injured CD36-null mice (e). N = 6 per group
Fig. 7 CD36-null mice are protected from efferocytosis-induced fibrosis. Twenty-one days after three times weekly doses of UV-treated MLE-12 cells, CD36-null mice has less fibrosis assessed by hyroxyproline assay (a) BAL fluid TGFβ measured by ELISA (b) and distribution of fibrosis assessed by histology (20×) of picrosiris red stained lungs slices of PBS treated control mice (c), UV MLE-12 injured WT mice (d), and UV MLE-12 injured CD36-null mice (e). N = 6 per groupCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 86

Metadata

Authors
Kim, K. K., Dotson, M. R., Agarwal, M., Yang, J., Bradley, P. B., Subbotina, N., Osterholzer, J. J., & Sisson, T. H.
Affiliations
University of Michigan (US)
Corresponding author
Kim, Kevin K.
Venue
Cell Death & Disease
Published
2018-10-17
Volume
9
Issue
11
Pages
1056-1056
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2897027697
Cited by
85
References
33
Citations by year
2026: 9 · 2025: 14 · 2024: 12 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 18 · 2019: 4
FWCI
6.22
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL108904)
  • Martin E. Galvin Fund for Pulmonary Fibrosis Research Pilot Grant
  • U.S. Department of Veterans Affairs (BX002120)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
efferocytosis, alveolar type II cells, alveolar epithelial cell apoptosis, pulmonary fibrosis, alveolar macrophages, CD36, caspase-3/7 activation, diphtheria toxin, MLE-12 cells, profibrotic gene expression, macrophage activation
MeSH terms
Animals, Bronchoalveolar Lavage Fluid, Cell Line, Diphtheria Toxin, Gene Expression Regulation, Humans, Macrophage Activation, Mice, Inbred C57BL, Mice, Transgenic, Phagocytosis, Pulmonary Alveoli, Pulmonary Fibrosis, Recombinant Fusion Proteins, Signal Transduction, Macrophages, Alveolar, Apoptosis, CD36 Antigens, Intercellular Signaling Peptides and Proteins, Pulmonary Surfactant-Associated Protein C, Mice, Caspase 3, Caspase 7, Alveolar Epithelial Cells, Primary Cell Culture, Heparin-binding EGF-like Growth Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis. https://app.cochat.ai/papers/10.1038/s41419-018-1074-z
The paper
Kim, K. K., Dotson, M. R., Agarwal, M., Yang, J., Bradley, P. B., Subbotina, N., Osterholzer, J. J., & Sisson, T. H. (2018). Efferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis. Cell Death & Disease. https://doi.org/10.1038/s41419-018-1074-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.